Cara Therapeutics (CARA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CARA | AMGN | CELG | GILD | BIIB |
| Company | Cara Therapeutics | Amgen Inc | Celgene Corp | Gilead Sciences Inc | Biogen Inc |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 0.6900 | 264.63 | 108.01 | 66.25 | 190.72 |
| High | 0.6958 | 269.38 | 108.59 | 66.83 | 194.52 |
| Low | 0.6500 | 260.68 | 107.27 | 66.16 | 189.44 |
| Last | 0.6610 | 268.93 | 108.24 | 66.76 | 194.38 |
| Change | -0.0290 | +6.18 | +0.11 | +0.60 | +3.86 |
| % Change | -4.20% | +2.35% | +0.10% | +0.91% | +2.03% |
| Volume | 350,823 | 3,379,993 | 191,230,496 | 10,656,795 | 1,599,570 |
| 20-Day Average Volume | 405,381 | 2,246,420 | 16,188,930 | 6,455,910 | 1,140,994 |
| Previous Close | 0.6900 | 262.75 | 108.13 | 66.16 | 190.52 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | No | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.8098 | 272.56 | 108.17 | 69.90 | 205.03 |
| 20-Day Raw Stochastic | 9.09% | 29.59% | 63.25% | 10.79% | 15.51% |
| 20-Day Relative Strength | 40.76% | 43.95% | 64.69% | 31.30% | 32.40% |
| Weighted Alpha | -78.09 | +7.67 | +46.30 | -24.32 | -36.99 |
| Today's Opinion | 72% Sell | 56% Sell | 100% Buy | 100% Sell | 100% Sell |
| Previous Opinion | 56% Sell | 56% Sell | 100% Buy | 100% Sell | 100% Sell |
| Last Month's Opinion | 24% Sell | 8% Sell | 100% Buy | 72% Sell | 100% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | -13.49% since 04/12/24 | +0.62% since 04/12/24 | -1.97% since 11/13/19 | -1.92% since 04/12/24 | -1.92% since 04/12/24 |
| Low | 0.6311 on 04/16/24 | 260.68 on 04/19/24 | 107.27 on 11/20/19 | 65.90 on 04/18/24 | 189.44 on 04/19/24 |
| High | 0.7839 on 04/15/24 | 270.93 on 04/15/24 | 110.53 on 11/14/19 | 68.46 on 04/15/24 | 199.53 on 04/15/24 |
| 1-Month | |||||
| %Chg | -25.73% since 03/19/24 | -1.03% since 03/19/24 | +5.14% since 10/18/19 | -9.06% since 03/19/24 | -11.09% since 03/19/24 |
| Low | 0.6311 on 04/16/24 | 260.68 on 04/19/24 | 102.40 on 10/21/19 | 65.90 on 04/18/24 | 189.44 on 04/19/24 |
| High | 0.9600 on 03/28/24 | 288.57 on 03/28/24 | 110.70 on 11/13/19 | 74.28 on 03/21/24 | 221.74 on 03/21/24 |
| 3-Month | |||||
| %Chg | +16.99% since 01/19/24 | -12.63% since 01/19/24 | +13.63% since 08/20/19 | -23.52% since 01/19/24 | -22.24% since 01/19/24 |
| Low | 0.5000 on 01/25/24 | 260.68 on 04/19/24 | 93.41 on 08/23/19 | 65.90 on 04/18/24 | 189.44 on 04/19/24 |
| High | 1.1500 on 03/04/24 | 329.72 on 02/05/24 | 110.70 on 11/13/19 | 81.06 on 01/25/24 | 252.17 on 01/22/24 |
| 6-Month | |||||
| %Chg | -51.58% since 10/19/23 | -4.16% since 10/19/23 | +14.14% since 05/20/19 | -14.89% since 10/19/23 | -24.45% since 10/19/23 |
| Low | 0.5000 on 01/25/24 | 249.70 on 10/31/23 | 89.08 on 07/23/19 | 65.90 on 04/18/24 | 189.44 on 04/19/24 |
| High | 1.4000 on 11/06/23 | 329.72 on 02/05/24 | 110.70 on 11/13/19 | 87.86 on 01/19/24 | 268.30 on 01/03/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 37,713 | 140,812,720 | 77,035,920 | 82,374,304 | 27,694,178 |
| Shares Outstanding, K | 54,656 | 535,919 | 711,714 | 1,245,077 | 145,361 |
| Annual Sales | 20,970,000 | 28,190,000,000 | 15,281,000,000 | 27,116,000,000 | 9,835,600,000 |
| Annual Net Income | -118,510,000 | 6,717,000,000 | 4,046,000,000 | 5,665,000,000 | 1,161,100,000 |
| Last Quarter Sales | 3,000,000 | 8,196,000,000 | 4,520,000,000 | 7,114,000,000 | 2,386,300,000 |
| Last Quarter Net Income | -32,340,000 | 767,000,000 | 1,691,000,000 | 1,429,000,000 | 249,700,000 |
| 60-Month Beta | 0.70 | 0.58 | 1.41 | 0.19 | -0.02 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.59 on 03/04/24 | 4.71 on 02/06/24 | 2.99 on 10/31/19 | 1.72 on 02/06/24 | 2.95 on 02/13/24 |
| Latest Earnings Date | 05/20/24 | 05/02/24 | 10/31/19 | 04/25/24 | 04/24/24 |
| Most Recent Dividend | N/A | 2.250 on 02/15/24 | N/A | 0.770 on 03/14/24 | N/A |
| Next Ex-Dividends Date | N/A | 05/16/24 | N/A | 03/14/24 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 14.16 | 10.99 | 9.96 | 13.05 |